There are a lot of studies with conflicting results about the correlation between blood
levels of vitamin D and lipid profile (total cholesterol, LDLc, HDLc) and the effect of
treatment with vitamin D supplements on it. This study aimed to investig
ate the effect of
vitamin D and calcium supplements on lipid profile.
This study included 59 volunteers who received these supplements for prevention of
osteoporosis as a prescription from orthopedic doctors between 11/2016 to 1/2018. The
average of age was 49±8 years. The plasma values of TC, LDLc, HDLc were measured
using enzymatic colorimetric method ( Biosystems kits ) in Tishreen hospital before
treatment and after two months. The results were analyzed by T-Student test, and P value
<0.05 was considered significant. The mean plasma levels of LDLc before treatment were
(100.983 ±28.36) mg/dl, and after two months of treatment were (102.249±27.478) mg/dl,
and the difference was not significant. The mean plasma levels of HDLc before treatment
were (68.056 ±14.369) mg/dl and after two months of treatment were (62.715 ± 14.39)
mg/dl, and the difference was significant. We advise to measure plasma lipid levels during
treatment with these supplements depending on the changes that observed in this study.
This study tries to know the rate of the deficiency of vitamin D experienced by Lattakian women as well as its accompanying diseases. It is conducted at a specific clinic in Lattakia in the period (2012-2013).
The study included a sample of 127 w
omen randomly chosen. It depended on laboratory results of the levels of vitamin D: normal rate, moderate deficiency, acute deficiency. It also depended on age group: Group1(20-50 years old): Group 2: (more than50 years old).
The study concludes that the rate levels are as follows: very high (84.26%), normal (15.74%), moderate deficiency (55.15)%, and acute deficiency (44.85%).
Symptoms based on age were as follows:
Group 1: clinical symptoms were more visible than diseases. The clinical symptoms were: 1-the muscular vatic (93.70%); 2 anxiety and depression (77.05%). Diseases were: 1-thyroied failure (12.5%), 2-hypertesion(6.25%).
Group 2: Diseases were more visible: The clinical symptoms were :1-anxiety (85.18%), 2-the muscular vatic (74.07%). Diseases were :1-cardiovasculardiseases (44.44%), 2-hypertension(37,03%).
